chitosan has been researched along with Bronchiectasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadinoto, K; Tran, TT | 1 |
| Aldosari, BN; Alfagih, IM; Aljunaidel, HA; Almarshidy, SS; Almurshedi, AS; Alquadeib, B; Eltahir, EKD; Mohamoud, AZ | 1 |
2 other study(ies) available for chitosan and Bronchiectasis
| Article | Year |
|---|---|
A Potential Quorum-Sensing Inhibitor for Bronchiectasis Therapy: Quercetin-Chitosan Nanoparticle Complex Exhibiting Superior Inhibition of Biofilm Formation and Swimming Motility of
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Biofilms; Bronchiectasis; Chemical Phenomena; Chitosan; Drug Carriers; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Molecular Structure; Nanoparticles; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Disease, Chronic Obstructive; Quercetin; Quorum Sensing; Solubility; Spectrum Analysis | 2021 |
Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Chitosan; Ciprofloxacin; Drug Carriers; Drug Liberation; Dry Powder Inhalers; Fibrosis; Kinetics; Lipids; Liposomes; Lung; Microbial Sensitivity Tests; Nanostructures; Particle Size; Static Electricity | 2021 |